Background: High-dose radiation is the main component of glioblastoma therapy. Unfortunately, radio-resistance is a common problem and a major contributor to tumor relapse. Understanding the molecular mechanisms driving response to radiation is critical for identifying regulatory routes that could be targeted to improve treatment response.
Background
Glioblastoma is the most common intracranial malignant brain tumor with an aggressive clinical course.
Standard of care entails maximally safe resection followed by radiotherapy with concomitant and adjuvant temozolomide. Nonetheless, the median overall survival remains approximately 16 months [1, 2] , and the recent addition of tumor-treating fields to the standard of care has only increased median overall survival to 20.5 months [1] . Recurrence occurs in part because glioblastoma uses sophisticated cellular mechanisms to repair DNA damage from double-stranded breaks caused by ionizing radiation, specifically homologous recombination and non-homologous end-joining. Thus, the repair machinery confers a mechanism for resistance to radiation therapy. Ionizing radiation can also cause base damage and single-strand breaks, which are repaired by base excision and single-strand break repair mechanisms, respectively [3] . A comprehensive analysis of molecular mechanisms driving resistance to chemotherapy and radiation is required to surpass major barriers and advance treatments for glioblastoma.
The Cancer Genome Atlas (TCGA) was instrumental in improving the classification and identification of tumor drivers [4] , but its datasets provide limited opportunities to investigate radiation response. Thus, studies using cell and murine models are still the best alternatives to evaluate radiation response at the genomic level. The list of biomarkers associated with radiation resistance in glioblastoma is still relatively small. Among the most relevant are FOXM1 [5, 6], STAT3 [6], L1CAM [7] , NOTCH1 [8] , RAD51 [9] , EZH2 [10] , CHK1/ATR [11] , COX-2 [12] , and XIAP [13] . Dissecting how gene expression is altered by ionizing radiation is critical to identify possible genes and * Correspondence: penalva@uthscsa.edu 2 Greheey Children's Research Institute, University of Texas Health Science Center at San Antonio, 78229 San Antonio USA Full list of author information is available at the end of the article † Equal contributorˆIn memoriam pathways that could increase radio-sensitivity. A few genomic studies [14, 15, 16] have explored this question, but these analyses were restricted to describing changes in transcription.
Gene expression is regulated at multiple levels, and RNA-mediated mechanisms such as splicing and translation are particularly relevant in cancer biology. A growing number of inhibitors against regulators of splicing and translation are being identified [17] . Splicing alterations are a common feature across cancer types and affect all hallmarks of cancer [18] . Numerous splicing regulators display altered expression in glioblastoma (e.g. PTBP1, hnRNPH, and RBM14) and function as oncogenic factors [19] . Importantly, a genome-wide study using patient-derived models revealed that transformation-specific depended on RNA splicing machinery. The SF3b-complex protein PHF5A was required for glioblastoma cells to survive, but not neural stem cells (NSCs). Moreover, genome-wide splicing alterations after PHF5A loss appear only in glioblastoma cells [20] . Translation regulation also plays a critical role in glioblastoma development. Many translation regulators such as elF4E, eEF2, Musashi1, HuR, IGF2BP3, and CPEB1 promote oncogenic activation in glioblastoma, and pathways linked to translation regulation (e.g., mTOR) promote cancer phenotypes [21] .
To elucidate expression responses to radiation, we conducted an integrated study in U251 and U343 glioblastoma cell lines covering transcription (mRNAs and lncRNAs), splicing, and translation. We determined that the downregulation of FOXM1 and members of the E2F family are likely the major drivers of observed alterations in cell cycle and DNA replication genes upon radiation exposure. Genes involved in RNA regulatory mechanisms were particularly affected at the transcription, splicing, and translation levels. In addition, we identified several oncogenic factors and genes associated with poor survival in glioblastoma that displayed increased expression upon radiation exposure. Importantly, many have been implicated in radio-resistance, and therefore, their inhibition in combination with radiation could increase therapy efficacy.
Methods
Cell culture and radiation treatment 
Overall strategy to identify gene expression alterations upon radiation
To identify the most relevant expression alterations in the early response to radiation, we analyzed samples from U251 and U343 cells collected at 0 (T0), 1 (T1), and 24 (T24) hours post-radiation. To capture the progressive dynamics of expression alterations, we compared T0 to T1 samples and T1 to T24 samples.
Our strategy to identify the most relevant alterations in expression with maximal statistical power was to combine all samples and use a design matrix with cell type defined as a covariate with time points ( Figure   S1 ).
Sequence data pre-processing and mapping
The quality of raw sequences reads from RNA-Seq and Ribo-Seq datasets were assessed using FastQC [22] .
Adaptor sequences and low-quality score (phred quality score < 5) bases were trimmed from RNA-Seq and as a guided reference annotation, allowing a mismatch of at most two positions. All the reads mapping to rRNA and tRNA sequences were filtered out before downstream analysis. Most reads in the Ribo-seq samples mapped to the coding domain sequence (CDS).
The distribution of fragment lengths for ribosome footprints was enriched in the 28-30 nucleotides range, as expected ( Figure S2 ). The ribosome density profiles exhibit high periodicity as within the CDS, as expected since ribosomes traverse three nucleotides at a time ( Figure S3 ). The periodicity analysis was performed using ribotricer [26] . The number of reads assigned to annotated genes included in the reference genome was obtained by htseq-count [27] . were captured along the second principal component (Supplementary Figure S1B ). Differential gene expression analysis was performed by employing the DESeq2 package [28] , with read counts from both U251 and U343 cell samples as inputs. We adjusted p-values controlling for the false discovery rate (adjusted p-value) using the Benjamini and Hochberg (BH) procedure [29] . Differentially expressed genes were defined with an adjusted p-value < 0.05
Differential gene expression analysis

Weighted gene co-expression network analysis
Weighted Gene Co-expression Network Analysis (WGCNA) [30] uses pairwise correlations on expression values to identify genes significantly co-expressed across samples. We used this approach to identify gene modules with significant co-expression variations as an effect of radiation. The entire set of expressed genes, defined here as those with one or higher transcripts per million higher (TPM), followed by variance stabilization) from U251 and U343 samples were clustered separately using the signed network strategy. We used the Z summary [31] statistic as a measure of calculating the degree of module preservation between U251 and U343 cells. Z summary is a composite statistic defined as the average of the density and connectivity based statistic. Thus, both density and connectivity are considered for defining the preservation of a module. Modules with Z summary > 5 were considered as significantly preserved. The expression profile of all genes in each co-expression module can be summarized as one "eigengene". We used the eigengene-based connectivity (kME) defined as the correlation of a gene with the corresponding module eigengene to assess the connectivity of genes in a module. The intramodular hub genes were then defined as genes with the highest module membership values (kME >0.9). All analysis was performed using the R package WGCNA. The proteincoding hub genes were then selected for gene ontology enrichment analysis.
Translational efficiency analysis
We used Riborex [32] to perform differential translational efficiency analysis. The underlying engine selected was DESeq2 [28] . issue, we performed a p-value correction using fdrtool [33] that re-estimates the variance using an empirical bayes approach.
Alternative splicing analysis
Alternative splicing analysis was performed using rMATS [34] . All reads were trimmed using cutadapt [35] with parameters (-u -13 -U -13) to ensure trimmed reads had equal lengths (138 bp). rMATs was run with default parameters in paired end mode (-t paired) and read length set to 138 bp (-len 138)
using GENCODE GTF (v25) and STAR index for GRCh38.
Gene ontology (GO) and pathway enrichment analysis
To classify the functions of differentially enriched genes, we performed GO enrichment, and the Reactome pathway [36] analysis using Panther [37] . For both analyses, we considered terms to be significant if BH adjusted p-values weree < 0.05, and fold enrichment is > 2.0. Further, we used REVIGO [38] to reduce redundancy of the enriched GO terms and visualize the semantic clustering of the identified top-scoring terms. We used STRING database (v10) [39] to construct protein-protein interaction networks and determine associations among genes in a given dataset. The interactions are based on experimental evidence procured from high-throughput experiments text-mining, and co-occurrence. Only high-confidence (0.70) nodes were retained.
Expression correlation analysis
Gene expression correlation analysis was done using Gliovis [40] using glioblastoma samples (RNAseq) from the TCGA. To select correlated genes, we used Pearson correlation, R > 0.3, and p-value < 0.05.
A list of genes affecting survival in glioblastoma was downloaded from GEPIA [41] . A list of long noncoding RNAs (lncRNAs) implicated in glioma development was obtained from Lnc2Cancer [42] . Drug-gene interactions were identified using the Drug-Gene Interaction Database [43] .
Results
Changes in global transcriptome profile in response to (Table S1) . Upregulated sets contain genes implicated in cell cycle arrest, apoptosis, and stress such as ZFP36, FBXW7, SMAD7, BTG2, and PLK3 (Table S1 ).
Since many alterations were observed when comparing the T1 vs. T24 time points (Table S1) Figure 1A ). Additionally, we identified several GO terms associated with mRNA metabolism, decay, translation, and ncRNA processing, suggesting active participation of RNA-mediated processes in radio-response ( Figure 1B ). Network analysis indicated the set of genes in these categories is highly interconnected ( Figure 1C and Table S2 ).
To expand the expression analysis, we employed WGCNA [30] to identify gene modules with significant co-expression variation as an effect of radiation.
All identified modules, along with the complete list of genes in each module, are shown in Supplementary Figure S4 and Table S3 . Seven modules were identified (Z summary > 5) as tightly regulated, independent of the cell line ( Figure S4E ). Among modules with the highest significant correlation (0.8, p-value< 1e−7), module 2 contains genes downregulated in T24, with many involved in cell cycle, metabolism mRNA metabolism, processing, splicing, and transport (Table S3 ), corroborating results described above.
Next, we investigated downregulated genes with the gene set enrichment analysis (GSEA) tool Enrichr [44] and conducted expression correlation analysis with Gliovis [40] . Based on their genomic binding profiles and effect of gene expression, FOXM1 and the E2F family of transcription factors emerged as potential regulators of a large group of cell cycle/DNA replication-related genes in the affected set ( Figure   2A , Table S4 ). In agreement, E2F1, E2F2, E2F8, and FOXM1 displayed a significant decrease upon radiation. FOXM1 and E2F factors have been previously implicated in chromatin remodeling, cell cycle regulation, DNA repair, and radio-resistance [45, 46] . All four factors are highly expressed in glioblastoma with respect to low-grade glioma. Importantly, they display high expression correlation with a large set of downregulated genes implicated in cell cycle and DNA repli- cation and among themselves in glioblastoma samples in TCGA ( Figure 2B -C).
Upregulated genes at T24 are preferentially associated with the extracellular matrix receptor interaction pathway, extracellular matrix organization, axonogenesis, and response to type I interferon ( Figure 3A , and Table S2 ). With respect to the extracellular matrix, we observed changes in the expression levels of several collagens (types II, IV, V, and XI), glycoproteins of the laminin family (subunits α, β, andγ), and also integrins (subunits α, and β) ( Figure 3B , and Table   S1 ). Collagen type IV is highly expressed in glioblastoma and implicated in tumor progression [47] . In addition, it has been observed that the activation of two integrins, ITGB3 and ITGB5, contributes to radioresistance [48] .
Radiation treatment also induced the expression of activation [49] . On the other hand, chronic activation of type I IFN signaling has been linked to adaptive resistance to therapy in many tumor types [50] .
Activation of oncogenic signals post-radiation could counteract treatment effects and later contribute to relapse. We searched the set of highly up-regulated genes post-radiation for previously identified radioresistance genes in glioblastoma, oncogenic factors and genes whose high expression is associated with poor prognosis (Table S5 ). In Table 1 , we list these genes according to their molecular function. Since several of these genes have never been characterized in the context of glioblastoma, our results open new opportunities to prevent radio-resistance and increase treatment efficiency. Importantly, there are inhibitors available against several of these proteins (Table S4) .
Changes in lncRNA profile in response to radiation lncRNAs have been implicated in the progression of glioblastoma [51] , but their role in response to ionizing radiation is still poorly understood. We identified 161 lncRNAs with expression alterations in T1 vs. T24
comparisons. Analysis of this set with LnC2Cancer
[42] identifieddentified several lncRNAs aberrantly expressed in cancer and with relevance to prognosis (Table S1). We also detected significant downregulation of MIR155HG, whose high expression is associated with glioma progression and poor survival [52] . Another downregulated lncRNA with relevance to prognosis is linc000152, whose increased expression has been observed in multiple tumor types [53, 53] . On the other hand, we observed a significant upregulation of two "oncogenic" lncRNAs, NEAT1 and FTX. NEAT1 is associated with tumor growth, grade, and recurrence rate in gliomas [54] , while FTX promotes cell proliferation and invasion through negatively regulating miR-342-3p [55] . Thus, if further studies corroborate NEAT1 and FTX as players in radio-resistance, targeting these lncRNAs should be considered to improve treatment response.
Effect of radiation on splicing
Alternative splicing impacts genes implicated in all hallmarks of cancer [56] and is an important component of changes in expression triggered by ionizing radiation [57] . All types of splicing events (exon skipping, alternative donor, and acceptor splice sites, multiple exclusive exons, and intron retention) were affected similarly upon exposure to radiation (Table   S7 ). At T24, we observed that transcripts associated Table 1 List of oncogenic factors, genes whose high expression is associated with poor survival and genes previously associated with radio-resistance in GBM that showed increased expression upon radiation. Genes are listed according to molecular function. Among those previously connected to glioblastoma development upon radiation, LGALS3 is the most extensively characterized.
LGALS3 is a galactosidasebinding lectin and non-classic RNA binding protein implicated in pre-mRNA splicing and regulation of proliferation, adhesion, and apoptosis;
LGALS3 also is a marker of the early stage of glioma [58] .
Differential translational efficiency
We used Ribo-seq [59] to identify changes in translation efficiency triggered by radiation. Translation, protein localization, and metabolism appear as top enriched terms among downregulated genes in T1 vs.
T24 comparisons (Tables S8-S9 ). In particular, several ribosomal proteins, along with translation initiation factors and mTOR, showed a significant decrease in translation efficiency ( Figure 5A-B) . Overall, these results indicate repression of the translation machinery post-radiation exposure and its strong auto-regulation.
Since changes in components of the translation machinery are occurring at all levels (transcription, splicing, and translation) at T24, we expect that major translational alterations take place in later stages of post-radiation.
In the upregulated set, we highlight three genes FTH1, APIP, and LRIG2 that could potentially counteract the impact of radiation (Table S10 ). FTH1 en- [64] .
Crosstalk between regulatory processes
Parallel analyses of transcription, splicing, and translation alterations in the early response to radiation provided an opportunity to identify crosstalk between different regulatory processes. The datasets showed little overlap, with just a few genes showing alterations in two different regulatory processes. However, we identified several shared GO terms when comparing the results of alternative splicing, mRNA levels, and translation efficiency (Table S10 ). These terms show two main groups of biological processes. The first group indicates that the expression of genes involved in DNA and RNA synthesis and metabolism is particularly compromised.
The second group is related to translation initiation. 
Discussion
We performed the first integrated analysis to define global changes associated with the early response to radiation in glioblastoma. Our approach allowed the E2F and FOXM1 targeting could be considered as an option to increase radio-sensitivity. Since the development of transcription factor inhibitors is very challenging, an alternative to be considered is the use of BET (bromodomain and external) inhibitors. BET is a family of proteins that function as readers for histone acetylation and modulates the transcription of oncogenic programs [86] . Recent studies in glioblastoma with a new BET inhibitor, dBET6, showed promising results and established that its effect on cancer phenotypes comes via disruption of the transcriptional program regulated by E2F1 [87] . Potential new targets to increase radio-sensitivity and prevent relapse Activation of oncogenic signals is an undesirable effect of radiation that could influence treatment response and contribute to relapse. We observed increased expression or translation and splicing alterations of a number of pro-oncogenic factors, genes whose high ex-pression is associated with poor survival and genes previously implicated in radio-resistance.
Among genes with the most marked increase in expression upon radiation, we identified members of the Notch pathway (HES2, NOTCH3, MFNG, and JAG2).
Notch activation has been linked to radio-resistance in glioblastoma, and Notch targeting improves the results of radiation treatment [90, 91] . We also identified several genes associated with the PI3K-Akt, Ras, and Rap1 signaling pathways that increased expression levels upon radiation exposure. Targeting these pathways has been explored as a therapeutic option in glioblastoma [92, 90] . Other oncogenic factors relevant to glioblastoma that had increased expression after radiation exposure include SRC, MUC1, LMO2, PML, PDGFRβ, BCL3, and BCL6.
Anti-apoptotic genes (BCL6, RRM2B, and IDO1) also showed increased expression upon radiation.
BCL6 is a member of the ZBTB family of transcription factors, which functions as a p53 pathway repressor.
The blockage of the interaction between BCL6 and its cofactors has been established as a novel therapeutic route to treat glioblastoma [93] . RRM2B is an enzyme essential for DNA synthesis and participates in Among genes whose high expression correlates with decreased survival in glioblastoma, we identified several components of the "matrisome" and associated factors (FAM20C, SEMA3F, ADAMTSL4, ADAMTS14, SERPINA5, and CRELD1). The core of the "ma- implicated in ECM regulation [98] were among those with high levels of expression upon radiation.
Conclusions
In conclusion, our results generated a list of candidates for combination therapy. Contracting the effect of oncogenic factors and genes linked to poor survival could increase radio-sensitivity and treatment efficiency. Importantly, there are known inhibitors against several of these proteins (Table S5) Additional file 5: Table S1 . Differentially expressed genes at different time points after radiation exposure in two glioblastoma cell lines.
Genes were tested for differential expression across two conditions using Gene ontology analysis of the gene set in Sheet 5.
Additional file 9: Table S5 . Oncogenes, genes contributing to radio-resistance and genes linked to GBM survival that are upregulatd upon radiation exposure.
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